Canada suspended the use of coronavirus vaccine from Astrazeneca against the background of the formation of blood clots in patients, writes ap.
As the Deputy Chairman of the National Advisory Committee on Immunization Shelly Dix, the drug is suspended for citizens over 55 years.
According to Dr. Joss Reimer from the target group in the introduction of a vaccine in the Canadian Province of Manitoba, the probability of thrombosis in the Astrazeneca vaccinated preparation is 1 to 100 thousand. It was previously believed that such a side effect was one of the millions of cases.
Earlier it was reported that the effectiveness of the vaccine from the coronavirus company Astrazeneca was 3 percent lower than previously declared. Studies have shown that from the flow of COVID-19 with Cymptoms, it saves 76 percent of cases, and not in 79, as it was thought before.
Currently, a number of European countries have suspended or banned vaccination with Astrazeneca due to the discovery of thrombosis in the intimidated patients. Meanwhile, the creators of the vaccine insist on its safety. The company stated that a detailed study of the health of more than 17 million people after vaccination showed the absence of data on the increased risk of the emergence of a pulmonary artery embolusion, deep vein thrombosis or thrombocytopenia.